...
search icon
vir-img

Vir Biotechnology Inc Share Price

VIR
NSQ
$9.48
-$0.34
(-3.46%)
1D
Industry: Biotechnology Sector: Health Care

Vir Biotechnology Inc Analyst Forecast

Vir Biotechnology Inc Share Price Chart

Vir Biotechnology Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.57B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.78M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.71
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.16 L
$10.94 H
$9.48

About Vir Biotechnology Inc, Common Stock

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California. more

Industry: BiotechnologySector: Health Care

Vir Biotechnology Inc Stock Returns

Time FrameVIRSectorS&P500
1-Week Return4.18%-0.69%-0.76%
1-Month Return22.96%-2.02%-0.71%
3-Month Return41.7%-0.79%-0.77%
6-Month Return89.6%10.67%2.91%
1-Year Return29.42%5.71%21.07%
3-Year Return-57.96%21.98%75.67%
5-Year Return-82.05%33.38%71.66%
10-Year Return-32.38%123.79%234.96%

Vir Biotechnology Inc Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue1.10B1.62B86.18M74.20M68.56M[{"date":"2021-12-31","value":67.79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.33,"profit":true},{"date":"2024-12-31","value":4.59,"profit":true},{"date":"2025-12-31","value":4.24,"profit":true}]
Cost of Revenue513.87M620.97M572.83M478.64M11.71M[{"date":"2021-12-31","value":82.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.25,"profit":true},{"date":"2024-12-31","value":77.08,"profit":true},{"date":"2025-12-31","value":1.89,"profit":true}]
Gross Profit581.54M994.83M(486.65M)(404.44M)56.85M[{"date":"2021-12-31","value":58.46,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-48.92,"profit":false},{"date":"2024-12-31","value":-40.65,"profit":false},{"date":"2025-12-31","value":5.71,"profit":true}]
Gross Margin53.09%61.57%(564.69%)(545.03%)82.92%[{"date":"2021-12-31","value":64.02,"profit":true},{"date":"2022-12-31","value":74.25,"profit":true},{"date":"2023-12-31","value":-680.96,"profit":false},{"date":"2024-12-31","value":-657.26,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Operating Expenses160.79M161.76M197.66M182.72M524.87M[{"date":"2021-12-31","value":30.63,"profit":true},{"date":"2022-12-31","value":30.82,"profit":true},{"date":"2023-12-31","value":37.66,"profit":true},{"date":"2024-12-31","value":34.81,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income420.75M833.07M(684.30M)(587.16M)(468.02M)[{"date":"2021-12-31","value":50.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-82.14,"profit":false},{"date":"2024-12-31","value":-70.48,"profit":false},{"date":"2025-12-31","value":-56.18,"profit":false}]
Total Non-Operating Income/Expense129.49M(50.70M)138.54M135.87M70.49M[{"date":"2021-12-31","value":93.47,"profit":true},{"date":"2022-12-31","value":-36.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.07,"profit":true},{"date":"2025-12-31","value":50.88,"profit":true}]
Pre-Tax Income549.80M754.28M(628.19M)(523.11M)(437.77M)[{"date":"2021-12-31","value":72.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-83.28,"profit":false},{"date":"2024-12-31","value":-69.35,"profit":false},{"date":"2025-12-31","value":-58.04,"profit":false}]
Income Taxes21.22M238.44M(13.08M)(1.15M)217.00K[{"date":"2021-12-31","value":8.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.48,"profit":false},{"date":"2024-12-31","value":-0.48,"profit":false},{"date":"2025-12-31","value":0.09,"profit":true}]
Income After Taxes528.58M515.84M(615.12M)(521.96M)(437.99M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.59,"profit":true},{"date":"2023-12-31","value":-116.37,"profit":false},{"date":"2024-12-31","value":-98.75,"profit":false},{"date":"2025-12-31","value":-82.86,"profit":false}]
Income From Continuous Operations528.58M515.84M(600.75M)(521.96M)(437.99M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.59,"profit":true},{"date":"2023-12-31","value":-113.65,"profit":false},{"date":"2024-12-31","value":-98.75,"profit":false},{"date":"2025-12-31","value":-82.86,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income528.58M515.84M(615.06M)(521.96M)(437.99M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.59,"profit":true},{"date":"2023-12-31","value":-116.36,"profit":false},{"date":"2024-12-31","value":-98.75,"profit":false},{"date":"2025-12-31","value":-82.86,"profit":false}]
EPS (Diluted)3.883.81(4.59)(3.82)(3.16)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.2,"profit":true},{"date":"2023-12-31","value":-118.3,"profit":false},{"date":"2024-12-31","value":-98.45,"profit":false},{"date":"2025-12-31","value":-81.44,"profit":false}]

Vir Biotechnology Inc Ratios

Vir Biotechnology Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

VIR
Cash Ratio 4.99
Current Ratio 5.54

Vir Biotechnology Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VIR
ROA (LTM) -24.36%
ROE (LTM) -45.73%

Vir Biotechnology Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VIR
Debt Ratio Lower is generally better. Negative is bad. 0.24
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.76

Vir Biotechnology Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VIR
Trailing PE NM
Forward PE 4.36
P/S (TTM) 23.03
P/B 2.06
Price/FCF NM
EV/R 18.19
EV/Ebitda 0.90

FAQs

What is Vir Biotechnology Inc share price today?

Vir Biotechnology Inc (VIR) share price today is $9.48

Can Indians buy Vir Biotechnology Inc shares?

Yes, Indians can buy shares of Vir Biotechnology Inc (VIR) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VIR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Vir Biotechnology Inc be purchased?

Yes, you can purchase fractional shares of Vir Biotechnology Inc (VIR) via the Vested app. You can start investing in Vir Biotechnology Inc (VIR) with a minimum investment of $1.

How to invest in Vir Biotechnology Inc shares from India?

You can invest in shares of Vir Biotechnology Inc (VIR) via Vested in three simple steps:

  • Click on Sign Up or Invest in VIR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Vir Biotechnology Inc shares
What is Vir Biotechnology Inc 52-week high and low stock price?

The 52-week high price of Vir Biotechnology Inc (VIR) is $10.94. The 52-week low price of Vir Biotechnology Inc (VIR) is $4.16.

What is Vir Biotechnology Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Vir Biotechnology Inc (VIR) is

What is Vir Biotechnology Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Vir Biotechnology Inc (VIR) is 2.06

What is Vir Biotechnology Inc dividend yield?

The dividend yield of Vir Biotechnology Inc (VIR) is 0.00%

What is the Market Cap of Vir Biotechnology Inc?

The market capitalization of Vir Biotechnology Inc (VIR) is $1.57B

What is Vir Biotechnology Inc's stock symbol?

The stock symbol (or ticker) of Vir Biotechnology Inc is VIR

How Can Investors Use Vir Biotechnology Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Vir Biotechnology Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Vir Biotechnology Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Vir Biotechnology Inc shares for Indian investors?

When investing in Vir Biotechnology Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Vir Biotechnology Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Vir Biotechnology Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Vir Biotechnology Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Vir Biotechnology Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top